Intravenous Immunoglobulin Treatment in Neurologic Disorders
Arch Neurol 56:1025-1027,1032, Sorensen,P.S., 1999
Is the Routine Use of Intravenous Immunoglobulin Treatment in Neurologic Disorders Justified?
Arch Neurol 56:1028-1032, Karussis,D.&Abramsky,O., 1999
Prognostic Factors of Guillain-Barre Syndrome After Intravenous Immunoglobulin or Plasma Exchange?
Neurol 53:598-604, Visser,L.H.,et al, 1999
Prevalence of Peripheral Neuropathy in Injection Drug Users
Neurol 53:592-597, Berger,A.R.,et al, 1999
Agreement and Variability in the Interpretation of Early CT Changes in Stroke Patients Qualifying for Intravenous rtPA Therapy
Stroke 30:1528-1533, Grotta,J.C.,et al, 1999
Pompholyx (Vesicular Eczema) After IV Immunoglobulin Therapy for Neurologic Disease
Neurol 53:1154-1155, Iannaccone,S.,et al, 1999
Intra-Arterial Cerebral Thrombolysis for Acutre Ischemic Stroke in a Community Hospital
AJNR 20:1682-1687,1580, Edwards,M.T.,et al, 1999
Predictors of Clinical Improvement,Angiographic Recanalization, and Intracranial Hemorrhage After Intra-Arterial Thrombolysis for Acute Ischemic Stroke
Stroke 30:2094-2100, Suarez,J.I.,et al, 1999
Therapeutic Plasma Exchange and Intravenous Immunoglobulin for Obsessive-Compulsive Disorder and Tic Disorders in Childhood
Lancet 354:1153-1158, Perlmutter,S.J.,et al, 1999
Expanding the Window for Thrombolytic Therapy in Acute Stroke, The Potential Role of Acute MRI for Patient Selection
Stroke 30:2230-2237, Albers,G.W., 1999
MRI Features of Intracerebral Hemorrhage Within 2 Hours from Symptom Onset
Stroke 30:2263-2267, Linfante,I.,et al, 1999
The Intensive Care Management of Acute Ischemic Stroke
The Neurologist 5:313-325, Deibert,E.&Diringer,M.N., 1999
Intra-Arterial Prourokinase for Acute Ischemic Stroke, The PROACT II Study:A Randomized Controlled Trial
JAMA 282:2003-2011, Furlan,A.,et al, 1999
Combined Intravenous and Intra-Arterial r-TPA Versus Intra-Arterial Therapy of Acute Ischemic Stroke, Emergency Management of Stroke (EMS) Bridging Trial
Stroke 30:2598-2605, Lewandowski,C.A.,et al, 1999
Recombinant Tissue-Type Plasminogen Activator (Alteplase) for Ischemic Stroke 3 to 5 Hours After Symptom Onset, The ATLANTIS Study:A Randomized Controlled Trial
JAMA 282:2019-2026, Clark,W.M.,et al, 1999
Diffuse Cerebral Vasculitis with Normal Results on Brain MR Imaging
AJR 173:1494-1496, Imbesi,S.G., 1999
Intravenous Immunoglobulin in the Treatment of Autoimmune Neuromuscular Diseases:Present Status and Practical Therapeutic Guidelines
Muscle & Nerve 22:1479-1497, Dalakas,M.C., 1999
Randomised Double-Blind Placebo-Controlled Trial of Thrombolytic Therapy with Intravenous Alteplase in Acute Ischaemic Stroke (ECASS II)
Lancet 352:1245-1251,1238, Hacke,W.,et al, 1998
Thrombolysis with Intravenous rtPA in a Series of 100 Cases of Acute Carotid Territory Stroke,Determination of Etiological,Topographic,and Radiological Outcome Factors
Stroke 29:2529-2540, Trouillas,P.,et al, 1998
Alteplase Not Yet Proven for Acute Ischaemic Stroke
Lancet 352:1238-1239,1245, Bath,P., 1998
Risk for Intracranial Hemorrhage after Tissue Plasminogen Activator Treatment for Acute Myocardial Infarction
Ann Int Med 129:597-604, Gurwitz,J.H.,et al, 1998
Optic Neuritis, Prognosis for Multiple Sclerosis from MRI, CSF, and HLA Findings
Neurol 50:708-714, Soderstrom,M.,et al, 1998
Inappropriate Use of Sumatriptan:Population Based Register and Interview Study
BMJ 316:1352-1353, Gaist,D.,et al, 1998
Clinicopath Conf
Subacute Sclerosing Panencephalitis, Case 15-1998, NEJM 338:1448-1456998., , 1998
Myelopathy Caused by Nitrous Oxide Toxicity
AJNR 19:894-896, 9941998., Pema,P.J.,et al, 1998
The Predictive Value of Early CT and Angiography for Fatal Hemispheric Swelling in Acute Stroke
AJNR 19:839-846, 9931998., Kucinski,T.,et al, 1998
Reversible Hyperintensity of Ant Pituitary Gland on T1-Wt MR in a Pt Receiving Temporary Parenteral Nutrition
AJNR 19:1287-1289, Okamoto,K.,et al, 1998
Clinicopath Conf
Wegener's Granulomatosis Involving Sinuses, Skull, and Cranial Nerves, Case 28-1998, NEJM 339:755-76, , 199, 1998
The Predictive Value of CSF Ologoclonal Banding for MS 5 Years After Optic Neuritis
Neurol 51:885-887, Cole,S.R.,et al, 1998
Cerebral Infarction in Young Adults
Neurol 50:890-894, Kittner,S.J.,et al, 1998
Illicit Drug-Associated Ischemic Stroke in the Baltimore-Washington Young Stroke Study
Neurol 50:1688-1693, Sloan,M.A.,et al, 1998
Results of Urgent Thrombolysis in Pts with Major Stroke and Atherothrombotic Occlusion of Cervical Int Carotid Art
AJNR 19:1169-1175, Endo,S.,et al, 1998
Local Intra-Arterial Thrombolysis in Acute Ischemic Stroke
Stroke 29:1894-1900, Gonner,F.,et al, 1998
Early Intravenous Thrombolysis with Recombinant Tissue-Type Plasminogen Activator in Vertebrobasilar Ischemic Stroke
Arch Neurol 55:466-469, 4501998., Grond,M.,et al, 1998
Early Intravenous Thrombolysis for Acute Ischemic Stroke in a Community-Based Approach
Stroke 29:1544-1549, Grond,M.,et al, 1998
Treating Ischemic Stroke as an Emergency
Arch Neurol 55:457-461, Adams,H.P., 1998
Cranial CT Interpret in Acute Stroke, Physician Accuracy in Determ Elig for Thrombolytic Therapy
JAMA 279:1293-1297, 13071998., Schriger,D.L.,et al, 1998
Role of CT Angiography in Patient Selection for Thrombolytic Therapy in Acute Hemispheric Stroke
Stroke 29:935-938, Wildermuth,S.,et al, 1998
Cost-Effectiveness of Tissue Plasminogen Activator for Acute Ischemic Stroke
Neurol 50:883-890, Fagan,S.C.,et al, 1998
Hemopericardium and Cardiac Tamponade after Thrombolysis for Acute Ischemic Stroke
Neurol 50:1857-1859, Kasner,S.E.,et al, 1998
Neurologists'Attitudes Regading rt-PA for Acute Ischemic Stroke
Neurol 50:1491-1494, Villar-Cordova,C.,et al, 1998
Further Evolution Toward Effective Therapy for Acute Ischemic Stroke
JAMA 279:1298-1303, 13041998., Fisher,M.&Bogousslavsky,J., 1998
Regional Ischemic & Ischemic Injury in Pts with Acute Mid Cereb Art Stroke as Defined by Early Diffusion-Wt & Perfusion-Wt MRI
Stroke 29:939-943, Rordorf,G.,et al, 1998
Baclofen Overdose:Drug Experimentation in a Group of Adolescents
Pediatrics 101:1045-1048, Perry,H.E.,et al, 1998
Intracerebral Haemorrhage Caused by Drug Abuse
Lancet 351:1029, McEvoy,A.W.,et al, 1998
Intravenous Immunoglobulin G Reduces MRI Activity in Relapsing Multiple Sclerosis
Neurol 50:1273-1281, Sorensen,P.S.,et al, 1998
Influence of Human Immunodeficiency Virus 1 Infection and Degree of Immunosuppression in the Clinical Characteristics and Outcome of Infective Endocarditis in Intravenous Drug Users
Arch Int Med 158:2043-2050, Ribera,E.,et al, 1998
Memory Impairment in Abstinent MDMA ("Ecstast") Users
Neurol 51:1532-1537, Bolla,K.I.,et al, 1998
Mild Traumatic Brain Injury,Toward Understanding Manifestations and Treatment
Arch Int Med 158:90-97, Kushner,D., 1998
Incidence and Clinical Consequence of the Purple Glove Syndrome in Patients Receiving Intravenous Phenytoin
Neurol 51:1034-1039,942, O'Brien,T.J.,et al, 1998